Loading...

Alexa Fluor® 700 anti-mouse CD45.2 Antibody Alexa Fluor® 700 anti-mouse CD45.2 Antibody

Pricing & Availability
Clone
104 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-5.2, LCA
Isotype
Mouse (SJL) IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
104_Alx700_020608
C57BL/6 mouse splenocytes stained with 104 Alexa Fluor® 700
  • 104_Alx700_020608
    C57BL/6 mouse splenocytes stained with 104 Alexa Fluor® 700
Compare all formats See Alexa Fluor® 700 spectral data
Cat # Size Price Quantity Check Availability Save
109821 25 µg DKK559
Check Availability


Need larger quantities of this item?
Request Bulk Quote
109822 100 µg DKK1278
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45.2 is an alloantigen of CD45, expressed by Ly5.2 bearing mouse strains (e.g., A, AKR, BALB/c, CBA/Ca, CBA/J, C3H/He, C57BL, C57BR, C57L, C58, DBA/1, DBA/2, NZB, SWR, 129). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in the mouse that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
B10.S mouse thymocytes and splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 700 under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor® 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor® 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3. 

Application References
  1. Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
  2. Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
  3. Suzuki K, et al. 2000. Immunity 13:691. (IHC)
  4. Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
  5. Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837.
  6. Pascal V, et al. 2007. J. Immunol. 179:1751.
  7. Burman AC, et al. 2007. Blood 110:1064.
  8. Kincaid EZ, et al. 2007. J. Immunol. 179:3187.
  9. Phan TG, et al. 2007. Nature Immunol. 8:992.
  10. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed
  11. Wen T, et al. 2013. PNAS. 110:6067. PubMed
  12. Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations
  1. Bradley CP et al. 2017. Cell host & microbe. 22(5):697-704 . PubMed
  2. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  3. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  4. Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed
  5. Herz J, et al. 2021. Neuron. 109:3609. PubMed
  6. Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed
  7. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  8. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  9. Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed
  10. du Halgouet A, et al. 2023. Immunity. 56:78. PubMed
  11. Arimoto KI, et al. 2023. Nat Commun. 14:251. PubMed
  12. Novaj A, et al. 2023. Int J Mol Sci. 24: . PubMed
  13. Sylvester MA, et al. 2022. Am J Physiol Renal Physiol. 322:F245. PubMed
  14. Guo A, et al. 2022. Nature. 607:135. PubMed
  15. Shiroshita K, et al. 2022. Cell Rep Methods. 2:100354. PubMed
  16. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  17. Haensel D, et al. 2023. Nat Commun. 14:2685. PubMed
  18. Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed
  19. Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed
  20. Basu S, et al. 2013. J Immunol Methods. 396:163. PubMed
  21. Chandran S, et al. 2020. Front Immunol. 11:787. PubMed
  22. Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed
  23. Page N, et al. 2018. Immunity. 48:937. PubMed
  24. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  25. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  26. Zinselmeyer B, et al. 2013. J Exp Med. 210:757. PubMed
  27. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  28. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  29. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  30. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  31. Ersching J et al. 2017. Immunity. 46(6):1045-1058 . PubMed
  32. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  33. Böttcher JP, et al. 2018. Cell. 172:1022. PubMed
  34. Blackburn CMR, et al. 2021. Atherosclerosis. 330:76. PubMed
  35. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  36. Semmrich M, et al. 2011. Mucosal Immunol. 0.3125. PubMed
  37. Kang S, et al. 2011. J Exp Med. 208:747. PubMed
  38. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  39. Louveau A, et al. 2018. Nat Neurosci. 21:1380. PubMed
  40. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  41. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  42. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  43. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  44. Ciecko AE, et al. 2019. Cell Rep. 29:3073. PubMed
  45. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  46. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  47. Amor C, et al. 2020. Nature. 583:127. PubMed
  48. Kretschmer B, et al. 2015. Immunobiology. 220: 964-975. PubMed
  49. Panciera T, et al. 2016. Cell Stem Cell. 19:725-737. PubMed
  50. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  51. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
  52. Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed
  53. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  54. Kinkel SA, et al. 2022. iScience. 25:104684. PubMed
  55. Trompette A, et al. 2022. Mucosal Immunol. :. PubMed
  56. DeFranco D 2014. Proc Natl Acad Sci U S A. 111:3224. PubMed
  57. Zenke S, et al. 2020. Immunity. 52(2):313-327. PubMed
  58. Di Genua C, et al. 2020. Cancer Cell. 37(5):690-704.e8.. PubMed
  59. Fallet B, et al. 2020. Cell Rep. 30:1013. PubMed
  60. Lee SS, et al. 2022. Commun Biol. 5:654. PubMed
  61. Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed
  62. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  63. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  64. Amos J, et al. 2015. J Virol. 89: 9485-9498. PubMed
  65. Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
  66. Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
  67. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  68. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  69. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  70. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
  71. Zaid A,et al. 2017. J Immunol. 10.4049/jimmunol.1700571. PubMed
  72. Duan H, et al. 2021. J Clin Invest. 131:. PubMed
  73. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  74. Luck H, et al. 2015. Cell Metab. 21 527 . PubMed
  75. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  76. Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed
  77. Port JR, et al. 2020. J Virol. 94:. PubMed
  78. Schilke RM, et al. 2020. Immunohorizons. 0.624305556. PubMed
  79. XS R, et al. 2015. Diabetes. 64 90. PubMed
  80. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  81. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  82. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  83. Nadrah K, et al. 2015. PLoS One. 10: 0136061. PubMed
  84. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  85. Nabet BY et al. 2017. Cell. 170(2):352-366 . PubMed
  86. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  87. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  88. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  89. Loo CS, et al. 2020. Immunity. 53:143. PubMed
  90. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  91. Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed
  92. Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed
  93. Guendel F, et al. 2020. Immunity. 53(5):1015-1032.e8. PubMed
  94. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  95. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  96. Kurowska-Stolarska M, et al. 2016. J Allergy Clin Immunol. S0091-6749(16)31132-0. PubMed
  97. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  98. Benci JL et al. 2016. Cell. 167(6):1540-1554 . PubMed
  99. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  100. Wilmore JR, et al. 2022. Front Immunol. 12:791095. PubMed
  101. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  102. Rustenhoven J, et al. 2021. Cell. 184(4):1000-1016.e27. PubMed
  103. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  104. Wang Y, et al. 2020. eLife. 9:e57438.. PubMed
  105. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  106. Sheppard S, et al. 2021. Cell Reports. 35(9):109210. PubMed
  107. Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed
  108. Loo Yau H, et al. 2021. Molecular Cell. 81(7):1469-1483.e8. PubMed
  109. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  110. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  111. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  112. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  113. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  114. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  115. Leruste A, et al. 2020. Cancer Cell. 36(6):597-612.e8.. PubMed
  116. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  117. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  118. Bradley CP et al. 2017. Cell host & microbe. 22(5):697-704 . PubMed
  119. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  120. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  121. Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed
  122. Herz J, et al. 2021. Neuron. 109:3609. PubMed
  123. Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed
  124. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  125. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  126. Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed
  127. du Halgouet A, et al. 2023. Immunity. 56:78. PubMed
  128. Arimoto KI, et al. 2023. Nat Commun. 14:251. PubMed
  129. Novaj A, et al. 2023. Int J Mol Sci. 24: . PubMed
  130. Sylvester MA, et al. 2022. Am J Physiol Renal Physiol. 322:F245. PubMed
  131. Guo A, et al. 2022. Nature. 607:135. PubMed
  132. Shiroshita K, et al. 2022. Cell Rep Methods. 2:100354. PubMed
  133. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  134. Haensel D, et al. 2023. Nat Commun. 14:2685. PubMed
  135. Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed
  136. Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed
  137. Basu S, et al. 2013. J Immunol Methods. 396:163. PubMed
  138. Chandran S, et al. 2020. Front Immunol. 11:787. PubMed
  139. Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed
  140. Page N, et al. 2018. Immunity. 48:937. PubMed
  141. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  142. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  143. Zinselmeyer B, et al. 2013. J Exp Med. 210:757. PubMed
  144. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  145. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  146. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  147. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  148. Ersching J et al. 2017. Immunity. 46(6):1045-1058 . PubMed
  149. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  150. Böttcher JP, et al. 2018. Cell. 172:1022. PubMed
  151. Blackburn CMR, et al. 2021. Atherosclerosis. 330:76. PubMed
  152. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  153. Semmrich M, et al. 2011. Mucosal Immunol. 0.3125. PubMed
  154. Kang S, et al. 2011. J Exp Med. 208:747. PubMed
  155. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  156. Louveau A, et al. 2018. Nat Neurosci. 21:1380. PubMed
  157. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  158. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  159. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  160. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  161. Ciecko AE, et al. 2019. Cell Rep. 29:3073. PubMed
  162. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  163. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  164. Amor C, et al. 2020. Nature. 583:127. PubMed
  165. Kretschmer B, et al. 2015. Immunobiology. 220: 964-975. PubMed
  166. Panciera T, et al. 2016. Cell Stem Cell. 19:725-737. PubMed
  167. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  168. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
  169. Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed
  170. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  171. Kinkel SA, et al. 2022. iScience. 25:104684. PubMed
  172. Trompette A, et al. 2022. Mucosal Immunol. :. PubMed
  173. DeFranco D 2014. Proc Natl Acad Sci U S A. 111:3224. PubMed
  174. Zenke S, et al. 2020. Immunity. 52(2):313-327. PubMed
  175. Di Genua C, et al. 2020. Cancer Cell. 37(5):690-704.e8.. PubMed
  176. Fallet B, et al. 2020. Cell Rep. 30:1013. PubMed
  177. Lee SS, et al. 2022. Commun Biol. 5:654. PubMed
  178. Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed
  179. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  180. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  181. Amos J, et al. 2015. J Virol. 89: 9485-9498. PubMed
  182. Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
  183. Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
  184. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  185. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  186. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  187. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
  188. Zaid A,et al. 2017. J Immunol. 10.4049/jimmunol.1700571. PubMed
  189. Duan H, et al. 2021. J Clin Invest. 131:. PubMed
  190. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  191. Luck H, et al. 2015. Cell Metab. 21 527 . PubMed
  192. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  193. Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed
  194. Port JR, et al. 2020. J Virol. 94:. PubMed
  195. Schilke RM, et al. 2020. Immunohorizons. 0.624305556. PubMed
  196. XS R, et al. 2015. Diabetes. 64 90. PubMed
  197. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  198. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  199. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  200. Nadrah K, et al. 2015. PLoS One. 10: 0136061. PubMed
  201. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  202. Nabet BY et al. 2017. Cell. 170(2):352-366 . PubMed
  203. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  204. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  205. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  206. Loo CS, et al. 2020. Immunity. 53:143. PubMed
  207. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  208. Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed
  209. Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed
  210. Guendel F, et al. 2020. Immunity. 53(5):1015-1032.e8. PubMed
  211. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  212. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  213. Kurowska-Stolarska M, et al. 2016. J Allergy Clin Immunol. S0091-6749(16)31132-0. PubMed
  214. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  215. Benci JL et al. 2016. Cell. 167(6):1540-1554 . PubMed
  216. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  217. Wilmore JR, et al. 2022. Front Immunol. 12:791095. PubMed
  218. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  219. Rustenhoven J, et al. 2021. Cell. 184(4):1000-1016.e27. PubMed
  220. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  221. Wang Y, et al. 2020. eLife. 9:e57438.. PubMed
  222. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  223. Sheppard S, et al. 2021. Cell Reports. 35(9):109210. PubMed
  224. Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed
  225. Loo Yau H, et al. 2021. Molecular Cell. 81(7):1469-1483.e8. PubMed
  226. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  227. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  228. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  229. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  230. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  231. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  232. Leruste A, et al. 2020. Cancer Cell. 36(6):597-612.e8.. PubMed
  233. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  234. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
RRID
AB_493730 (BioLegend Cat. No. 109821)
AB_493731 (BioLegend Cat. No. 109822)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Suzuki K, et al. 2000. Immunity 13:691.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45.2 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45.2 Reagents Request Custom Conjugation
Description Clone Applications
PE/Dazzle™ 594 anti-mouse CD45.2 104 FC
Purified anti-mouse CD45.2 (Maxpar® Ready) 104 FC,CyTOF®
Brilliant Violet 711™ anti-mouse CD45.2 104 FC
Alexa Fluor® 594 anti-mouse CD45.2 104 IHC-F,SB
APC/Fire™ 750 anti-mouse CD45.2 104 FC
TotalSeq™-A0157 anti-mouse CD45.2 104 PG
TotalSeq™-B0157 anti-mouse CD45.2 104 PG
TotalSeq™-C0157 anti-mouse CD45.2 104 PG
Brilliant Violet 750™ anti-mouse CD45.2 104 FC
Spark Blue™ 550 anti-mouse CD45.2 104 FC
Spark NIR™ 685 anti-mouse CD45.2 104 FC
Biotin anti-mouse CD45.2 104 FC
FITC anti-mouse CD45.2 104 FC
PE anti-mouse CD45.2 104 FC
Purified anti-mouse CD45.2 104 FC,Block,IHC-F,IP
APC anti-mouse CD45.2 104 FC
Alexa Fluor® 488 anti-mouse CD45.2 104 FC
Pacific Blue™ anti-mouse CD45.2 104 FC
Alexa Fluor® 700 anti-mouse CD45.2 104 FC
Alexa Fluor® 647 anti-mouse CD45.2 104 FC
APC/Cyanine7 anti-mouse CD45.2 104 FC
PerCP anti-mouse CD45.2 104 FC
PerCP/Cyanine5.5 anti-mouse CD45.2 104 FC
PE/Cyanine7 anti-mouse CD45.2 104 FC
Brilliant Violet 421™ anti-mouse CD45.2 104 FC
Brilliant Violet 570™ anti-mouse CD45.2 104 FC
Brilliant Violet 650™ anti-mouse CD45.2 104 FC
Brilliant Violet 510™ anti-mouse CD45.2 104 FC
Brilliant Violet 785™ anti-mouse CD45.2 104 FC
Brilliant Violet 605™ anti-mouse CD45.2 104 FC
Spark UV™ 387 anti-mouse CD45.2 104 FC
Spark Blue™ 574 anti-mouse CD45.2 (Flexi-Fluor™) 104 FC
Spark Red™ 718 anti-mouse CD45.2 (Flexi-Fluor™) 104 FC
Spark YG™ 581 anti-mouse CD45.2 (Flexi-Fluor™) 104 FC
Spark YG™ 593 anti-mouse CD45.2 (Flexi-Fluor™) Antibody 104 FC
Go To Top Version: 2    Revision Date: 06/27/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
104 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-5.2, LCA
Isotype
Mouse (SJL) IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
104_Alx700_020608
C57BL/6 mouse splenocytes stained with 104 Alexa Fluor® 700
  • 104_Alx700_020608
    C57BL/6 mouse splenocytes stained with 104 Alexa Fluor® 700
Compare all formats See Alexa Fluor® 700 spectral data
Cat # Size Price Quantity Check Availability Save
109821 25 µg DKK559
Check Availability


Need larger quantities of this item?
Request Bulk Quote
109822 100 µg DKK1278
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45.2 is an alloantigen of CD45, expressed by Ly5.2 bearing mouse strains (e.g., A, AKR, BALB/c, CBA/Ca, CBA/J, C3H/He, C57BL, C57BR, C57L, C58, DBA/1, DBA/2, NZB, SWR, 129). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in the mouse that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
B10.S mouse thymocytes and splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 700 under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor® 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor® 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3. 

Application References
  1. Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
  2. Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
  3. Suzuki K, et al. 2000. Immunity 13:691. (IHC)
  4. Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
  5. Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837.
  6. Pascal V, et al. 2007. J. Immunol. 179:1751.
  7. Burman AC, et al. 2007. Blood 110:1064.
  8. Kincaid EZ, et al. 2007. J. Immunol. 179:3187.
  9. Phan TG, et al. 2007. Nature Immunol. 8:992.
  10. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed
  11. Wen T, et al. 2013. PNAS. 110:6067. PubMed
  12. Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations
  1. Bradley CP et al. 2017. Cell host & microbe. 22(5):697-704 . PubMed
  2. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  3. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  4. Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed
  5. Herz J, et al. 2021. Neuron. 109:3609. PubMed
  6. Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed
  7. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  8. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  9. Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed
  10. du Halgouet A, et al. 2023. Immunity. 56:78. PubMed
  11. Arimoto KI, et al. 2023. Nat Commun. 14:251. PubMed
  12. Novaj A, et al. 2023. Int J Mol Sci. 24: . PubMed
  13. Sylvester MA, et al. 2022. Am J Physiol Renal Physiol. 322:F245. PubMed
  14. Guo A, et al. 2022. Nature. 607:135. PubMed
  15. Shiroshita K, et al. 2022. Cell Rep Methods. 2:100354. PubMed
  16. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  17. Haensel D, et al. 2023. Nat Commun. 14:2685. PubMed
  18. Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed
  19. Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed
  20. Basu S, et al. 2013. J Immunol Methods. 396:163. PubMed
  21. Chandran S, et al. 2020. Front Immunol. 11:787. PubMed
  22. Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed
  23. Page N, et al. 2018. Immunity. 48:937. PubMed
  24. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  25. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  26. Zinselmeyer B, et al. 2013. J Exp Med. 210:757. PubMed
  27. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  28. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  29. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  30. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  31. Ersching J et al. 2017. Immunity. 46(6):1045-1058 . PubMed
  32. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  33. Böttcher JP, et al. 2018. Cell. 172:1022. PubMed
  34. Blackburn CMR, et al. 2021. Atherosclerosis. 330:76. PubMed
  35. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  36. Semmrich M, et al. 2011. Mucosal Immunol. 0.3125. PubMed
  37. Kang S, et al. 2011. J Exp Med. 208:747. PubMed
  38. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  39. Louveau A, et al. 2018. Nat Neurosci. 21:1380. PubMed
  40. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  41. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  42. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  43. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  44. Ciecko AE, et al. 2019. Cell Rep. 29:3073. PubMed
  45. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  46. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  47. Amor C, et al. 2020. Nature. 583:127. PubMed
  48. Kretschmer B, et al. 2015. Immunobiology. 220: 964-975. PubMed
  49. Panciera T, et al. 2016. Cell Stem Cell. 19:725-737. PubMed
  50. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  51. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
  52. Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed
  53. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  54. Kinkel SA, et al. 2022. iScience. 25:104684. PubMed
  55. Trompette A, et al. 2022. Mucosal Immunol. :. PubMed
  56. DeFranco D 2014. Proc Natl Acad Sci U S A. 111:3224. PubMed
  57. Zenke S, et al. 2020. Immunity. 52(2):313-327. PubMed
  58. Di Genua C, et al. 2020. Cancer Cell. 37(5):690-704.e8.. PubMed
  59. Fallet B, et al. 2020. Cell Rep. 30:1013. PubMed
  60. Lee SS, et al. 2022. Commun Biol. 5:654. PubMed
  61. Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed
  62. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  63. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  64. Amos J, et al. 2015. J Virol. 89: 9485-9498. PubMed
  65. Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
  66. Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
  67. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  68. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  69. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  70. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
  71. Zaid A,et al. 2017. J Immunol. 10.4049/jimmunol.1700571. PubMed
  72. Duan H, et al. 2021. J Clin Invest. 131:. PubMed
  73. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  74. Luck H, et al. 2015. Cell Metab. 21 527 . PubMed
  75. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  76. Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed
  77. Port JR, et al. 2020. J Virol. 94:. PubMed
  78. Schilke RM, et al. 2020. Immunohorizons. 0.624305556. PubMed
  79. XS R, et al. 2015. Diabetes. 64 90. PubMed
  80. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  81. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  82. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  83. Nadrah K, et al. 2015. PLoS One. 10: 0136061. PubMed
  84. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  85. Nabet BY et al. 2017. Cell. 170(2):352-366 . PubMed
  86. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  87. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  88. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  89. Loo CS, et al. 2020. Immunity. 53:143. PubMed
  90. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  91. Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed
  92. Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed
  93. Guendel F, et al. 2020. Immunity. 53(5):1015-1032.e8. PubMed
  94. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  95. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  96. Kurowska-Stolarska M, et al. 2016. J Allergy Clin Immunol. S0091-6749(16)31132-0. PubMed
  97. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  98. Benci JL et al. 2016. Cell. 167(6):1540-1554 . PubMed
  99. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  100. Wilmore JR, et al. 2022. Front Immunol. 12:791095. PubMed
  101. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  102. Rustenhoven J, et al. 2021. Cell. 184(4):1000-1016.e27. PubMed
  103. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  104. Wang Y, et al. 2020. eLife. 9:e57438.. PubMed
  105. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  106. Sheppard S, et al. 2021. Cell Reports. 35(9):109210. PubMed
  107. Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed
  108. Loo Yau H, et al. 2021. Molecular Cell. 81(7):1469-1483.e8. PubMed
  109. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  110. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  111. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  112. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  113. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  114. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  115. Leruste A, et al. 2020. Cancer Cell. 36(6):597-612.e8.. PubMed
  116. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  117. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  118. Bradley CP et al. 2017. Cell host & microbe. 22(5):697-704 . PubMed
  119. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  120. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  121. Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed
  122. Herz J, et al. 2021. Neuron. 109:3609. PubMed
  123. Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed
  124. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  125. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  126. Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed
  127. du Halgouet A, et al. 2023. Immunity. 56:78. PubMed
  128. Arimoto KI, et al. 2023. Nat Commun. 14:251. PubMed
  129. Novaj A, et al. 2023. Int J Mol Sci. 24: . PubMed
  130. Sylvester MA, et al. 2022. Am J Physiol Renal Physiol. 322:F245. PubMed
  131. Guo A, et al. 2022. Nature. 607:135. PubMed
  132. Shiroshita K, et al. 2022. Cell Rep Methods. 2:100354. PubMed
  133. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  134. Haensel D, et al. 2023. Nat Commun. 14:2685. PubMed
  135. Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed
  136. Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed
  137. Basu S, et al. 2013. J Immunol Methods. 396:163. PubMed
  138. Chandran S, et al. 2020. Front Immunol. 11:787. PubMed
  139. Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed
  140. Page N, et al. 2018. Immunity. 48:937. PubMed
  141. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  142. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  143. Zinselmeyer B, et al. 2013. J Exp Med. 210:757. PubMed
  144. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  145. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  146. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  147. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  148. Ersching J et al. 2017. Immunity. 46(6):1045-1058 . PubMed
  149. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  150. Böttcher JP, et al. 2018. Cell. 172:1022. PubMed
  151. Blackburn CMR, et al. 2021. Atherosclerosis. 330:76. PubMed
  152. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  153. Semmrich M, et al. 2011. Mucosal Immunol. 0.3125. PubMed
  154. Kang S, et al. 2011. J Exp Med. 208:747. PubMed
  155. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  156. Louveau A, et al. 2018. Nat Neurosci. 21:1380. PubMed
  157. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  158. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  159. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  160. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  161. Ciecko AE, et al. 2019. Cell Rep. 29:3073. PubMed
  162. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  163. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  164. Amor C, et al. 2020. Nature. 583:127. PubMed
  165. Kretschmer B, et al. 2015. Immunobiology. 220: 964-975. PubMed
  166. Panciera T, et al. 2016. Cell Stem Cell. 19:725-737. PubMed
  167. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  168. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
  169. Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed
  170. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  171. Kinkel SA, et al. 2022. iScience. 25:104684. PubMed
  172. Trompette A, et al. 2022. Mucosal Immunol. :. PubMed
  173. DeFranco D 2014. Proc Natl Acad Sci U S A. 111:3224. PubMed
  174. Zenke S, et al. 2020. Immunity. 52(2):313-327. PubMed
  175. Di Genua C, et al. 2020. Cancer Cell. 37(5):690-704.e8.. PubMed
  176. Fallet B, et al. 2020. Cell Rep. 30:1013. PubMed
  177. Lee SS, et al. 2022. Commun Biol. 5:654. PubMed
  178. Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed
  179. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  180. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  181. Amos J, et al. 2015. J Virol. 89: 9485-9498. PubMed
  182. Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
  183. Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
  184. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  185. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  186. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  187. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
  188. Zaid A,et al. 2017. J Immunol. 10.4049/jimmunol.1700571. PubMed
  189. Duan H, et al. 2021. J Clin Invest. 131:. PubMed
  190. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  191. Luck H, et al. 2015. Cell Metab. 21 527 . PubMed
  192. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  193. Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed
  194. Port JR, et al. 2020. J Virol. 94:. PubMed
  195. Schilke RM, et al. 2020. Immunohorizons. 0.624305556. PubMed
  196. XS R, et al. 2015. Diabetes. 64 90. PubMed
  197. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  198. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  199. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  200. Nadrah K, et al. 2015. PLoS One. 10: 0136061. PubMed
  201. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  202. Nabet BY et al. 2017. Cell. 170(2):352-366 . PubMed
  203. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  204. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  205. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  206. Loo CS, et al. 2020. Immunity. 53:143. PubMed
  207. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  208. Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed
  209. Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed
  210. Guendel F, et al. 2020. Immunity. 53(5):1015-1032.e8. PubMed
  211. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  212. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  213. Kurowska-Stolarska M, et al. 2016. J Allergy Clin Immunol. S0091-6749(16)31132-0. PubMed
  214. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  215. Benci JL et al. 2016. Cell. 167(6):1540-1554 . PubMed
  216. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  217. Wilmore JR, et al. 2022. Front Immunol. 12:791095. PubMed
  218. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  219. Rustenhoven J, et al. 2021. Cell. 184(4):1000-1016.e27. PubMed
  220. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  221. Wang Y, et al. 2020. eLife. 9:e57438.. PubMed
  222. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  223. Sheppard S, et al. 2021. Cell Reports. 35(9):109210. PubMed
  224. Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed
  225. Loo Yau H, et al. 2021. Molecular Cell. 81(7):1469-1483.e8. PubMed
  226. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  227. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  228. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  229. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  230. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  231. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  232. Leruste A, et al. 2020. Cancer Cell. 36(6):597-612.e8.. PubMed
  233. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  234. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
RRID
AB_493730 (BioLegend Cat. No. 109821)
AB_493731 (BioLegend Cat. No. 109822)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Suzuki K, et al. 2000. Immunity 13:691.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45.2 on UniProt.org

Other Formats

View All CD45.2 Reagents Request Custom Conjugation
Description Clone Applications
PE/Dazzle™ 594 anti-mouse CD45.2 104 FC
Purified anti-mouse CD45.2 (Maxpar® Ready) 104 FC,CyTOF®
Brilliant Violet 711™ anti-mouse CD45.2 104 FC
Alexa Fluor® 594 anti-mouse CD45.2 104 IHC-F,SB
APC/Fire™ 750 anti-mouse CD45.2 104 FC
TotalSeq™-A0157 anti-mouse CD45.2 104 PG
TotalSeq™-B0157 anti-mouse CD45.2 104 PG
TotalSeq™-C0157 anti-mouse CD45.2 104 PG
Brilliant Violet 750™ anti-mouse CD45.2 104 FC
Spark Blue™ 550 anti-mouse CD45.2 104 FC
Spark NIR™ 685 anti-mouse CD45.2 104 FC
Biotin anti-mouse CD45.2 104 FC
FITC anti-mouse CD45.2 104 FC
PE anti-mouse CD45.2 104 FC
Purified anti-mouse CD45.2 104 FC,Block,IHC-F,IP
APC anti-mouse CD45.2 104 FC
Alexa Fluor® 488 anti-mouse CD45.2 104 FC
Pacific Blue™ anti-mouse CD45.2 104 FC
Alexa Fluor® 700 anti-mouse CD45.2 104 FC
Alexa Fluor® 647 anti-mouse CD45.2 104 FC
APC/Cyanine7 anti-mouse CD45.2 104 FC
PerCP anti-mouse CD45.2 104 FC
PerCP/Cyanine5.5 anti-mouse CD45.2 104 FC
PE/Cyanine7 anti-mouse CD45.2 104 FC
Brilliant Violet 421™ anti-mouse CD45.2 104 FC
Brilliant Violet 570™ anti-mouse CD45.2 104 FC
Brilliant Violet 650™ anti-mouse CD45.2 104 FC
Brilliant Violet 510™ anti-mouse CD45.2 104 FC
Brilliant Violet 785™ anti-mouse CD45.2 104 FC
Brilliant Violet 605™ anti-mouse CD45.2 104 FC
Spark UV™ 387 anti-mouse CD45.2 104 FC
Spark Blue™ 574 anti-mouse CD45.2 (Flexi-Fluor™) 104 FC
Spark Red™ 718 anti-mouse CD45.2 (Flexi-Fluor™) 104 FC
Spark YG™ 581 anti-mouse CD45.2 (Flexi-Fluor™) 104 FC
Spark YG™ 593 anti-mouse CD45.2 (Flexi-Fluor™) Antibody 104 FC
Go To Top Version: 2    Revision Date: 06/27/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account